GlassScriptPhysician profile
Nancy M Johnson
NPI 1053913392
$2,240.68
in general payments reported to CMS, 2019-2025
17 companies · $1,369 in 2025
The $1,369 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $376 · 2024: $312 · 2025: $1,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,057.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $396.93 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $366.64 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Axsome Therapeutics, INC. | $236.53 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $172.18 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $152.77 | 2023-2025 | Spravato, Invega Trinza, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $150.34 | 2022-2025 | Caplyta |
| Tris Pharma INC | $113.20 | 2025 | Dyanavel Xr, Onyda Xr |
| E.R. Squibb & Sons, L.L.C. | $104.07 | 2025 | Cobenfy |
| Alkermes, INC. | $98.58 | 2022-2025 | Lybalvi, Vivitrol |
| Takeda Pharmaceuticals U.S.A., INC. | $82.99 | 2023-2025 | Trintellix |
| Bausch Health US, LLC | $82.31 | 2022-2025 | Aplenzin, Wellbutrin |
| Lundbeck LLC | $74.98 | 2024-2025 | Rexulti, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $65.26 | 2025 | |
| Vanda Pharmaceuticals INC. | $63.31 | 2023-2025 | Fanapt, Hetlioz |
| Corium, LLC | $52.01 | 2024-2025 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.17 | 2023 | Jornay Pm |
| Owp Pharmaceuticals, INC. | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.